Evidence map›Paper›PMID 42711738›Full record

ArticleJournal of intensive care2026

Analysis of the pulmonary microbiome in ARDS patients using bronchoalveolar lavage fluid metagenomic next-generation sequencing: a retrospective observational study.

Xingchen Gao, Ruiqi Qin, Jing He

Abstract read
In one paragraph

Article in Journal of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xingchen GaoDepartment of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China.
Ruiqi QinDepartment of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China.
Jing HeDepartment of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China. 303945@hospital.cqmu.edu.cn.ORCID https://orcid.org/0009-0005-4865-5369

Funding

Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University kryc-yq-2127Science and technology research project of Chongqing Education Commission KJQN202300410
6 · The paper itself

Abstract

backgroundAcute respiratory distress syndrome (ARDS) exhibits significant clinical heterogeneity, with inflammatory subphenotypes (hypoinflammatory and hyperinflammatory) representing a key axis for precision medicine. The role of the pulmonary microbiome in these subphenotypes remains poorly understood.

methodsThis retrospective study enrolled 159 ARDS patients. Using a validated machine-learning classifier, patients were stratified into hypoinflammatory (n=92) and hyperinflammatory (n=67) groups. Bronchoalveolar lavage fluid (BALF) was analyzed by metagenomic next-generation sequencing (mNGS) and conventional microbiological testing (CMT). Clinical characteristics, pathogen profiles, and pulmonary microbiome composition were compared between groups.

resultsPatients in the hyperinflammatory phenotype had more severe disease, with significantly higher in-hospital mortality (65.7% vs. 30.4%, P < 0.001) and 28-day mortality (53.7% vs. 22.8%, P < 0.001). mNGS demonstrated superior diagnostic performance, identifying pathogens in 18.2% of cases that were negative by conventional microbiological testing (CMT), whereas CMT alone detected pathogens in only 2.5% of mNGS-negative cases. mNGS showed significant advantages in viral detection (74.5% vs. 28.2%, P < 0.001) and in the identification of mixed infections (74.5% vs. 41.1%, P < 0.001). Acinetobacter baumannii was the most prevalent species in both phenotypes; however, the hyperinflammatory phenotype was enriched for Klebsiella pneumoniae, Legionella pneumophila, and influenza A (H1N1), whereas Stenotrophomonas maltophilia and herpesviruses were more prevalent in the hypoinflammatory phenotype. Species richness was significantly reduced in the hyperinflammatory phenotype (Chao1, P < 0.001; ACE, P = 0.001). In adjusted analyses, this association remained virtually unchanged after adjustment for ARDS etiological category and pulmonary vs. extrapulmonary ARDS, and remained significant in the fully adjusted model additionally accounting for age, sex, and immunosuppression (Chao1: P = 0.002; ACE: P = 0.003). Evenness indices (Shannon/Simpson) and overall community structure (β-diversity; PERMANOVA, P = 0.156) did not differ between phenotypes, suggesting a selective depletion of rare, low-abundance taxa rather than a global restructuring of the pulmonary microbiota. Linear discriminant analysis effect size (LEfSe) identified differentially abundant taxa of exploratory significance: the hyperinflammatory phenotype was enriched for Bifidobacterium dentium and Gemella sanguinis, whereas the hypoinflammatory phenotype was enriched for commensals such as Streptococcus mitis. Network analysis revealed well-defined positive and negative correlations between pathogens and commensal taxa.

conclusionsThe hyperinflammatory phenotype of ARDS is characterized by greater clinical severity and a distinct pulmonary microbiome signature. Metagenomic next-generation sequencing (mNGS) substantially outperforms conventional methods for etiological diagnosis. LEfSe analysis identified differentially enriched taxa, with the hyperinflammatory phenotype enriched for microorganisms that typically colonize the oral cavity or gut (e.g., Bifidobacterium dentium), suggesting potential microbial translocation along the oral-lung or gut-lung axis. These findings provide a novel microbiome dimension for the precision subphenotyping of ARDS.

Indexed as

Acute respiratory distress syndromeBronchoalveolar lavage fluidInflammatory subphenotypesMetagenomic next-generation sequencingPulmonary microbiome

Identifiers

PMID42711738
PMCPMC13551742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.